Speakers

Adam Wicks is shareholder in Buchanan's Pittsburgh office and leads the firm's Private Equity and Venture Capital Practice Group. As a strategic, business-minded negotiator, Adam's business transactions practice focuses on representing private equity and venture capital firms, independent sponsors, family offices and other sources of private capital and their portfolio companies in their corporate development, investment and acquisition strategies. Additionally, Adam regularly represents private business owners exploring the sale of their business and other strategic transactions.

Adam also serves as outside corporate counsel to clients ranging from startups to publicly-traded companies, advising on entity formation and corporate governance, financings and offerings, mergers and acquisitions (M&A), federal and state securities law compliance, commercial matters, and connecting his clients to key professionals and experts in other practice areas within Buchanan as various needs arise.

Adam's clients span a variety of industries including software, retail, security and fire alarm and protection, sports and gaming, medical devices, residential and commercial services, manufacturing, and professional services. Adam has received Best Lawyers: Ones to Watch recognition in the Corporate Law and Securities / Capital Markets Law categories since 2021, and Super Lawyers Pennsylvania Rising Stars recognition since 2023.

Andrew C. Davison is Chairman, President, and CEO of Forma Medical Inc., the orthopedic medical device company he co-founded that develops minimally invasive solutions for foot and ankle surgery, including the OptimalMTP™ system for first MTP joint fusion. A Penn State Schreyer Honors College graduate with a B.S. in Mechanical Engineering and an M.S. in Mechanical Engineering from the University of Delaware, Davison has spent more than 15 years in medical device product development, commercialization, and leadership. His experience includes staff engineering roles at DePuy Synthes (Johnson & Johnson) focused on craniofacial and patient-specific implants, leading Trauma Division product development at Globus Medical (multiple FDA clearances and launches), and co-leading SIG Medical from concept through a successful exit. He later consulted for Zimmer Biomet and currently advises Horn Entrepreneurship at the University of Delaware. Davison is a named inventor on numerous patents related to surgical guides and implants and is driven by translating strong biomechanics into less invasive procedures that improve patient outcomes. 
 

Tina is Co-Leader of the firm's Life Sciences Industry Team, and a shareholder in the FDA/Biotechnology group. She focuses her practice on issues related to the approval, regulation, promotion, sale and reimbursement of drugs, medical devices, biologics, dietary supplements, foods and cannabis-related products.

Tina assists clients in their interactions with various federal agencies including the following:

• Food and Drug Administration (FDA)

• Centers for Medicare & Medicaid Services (CMS)

• Drug Enforcement Administration (DEA)

• Federal Trade Commission (FTC)

In addition to advising clients on how to obtain approvals for their FDA-regulated products, Tina's experience includes reviewing and revising the labeling of drugs, medical devices, foods and dietary supplements to ensure compliance with the FDA law and regulations. She works with clients to petition the FDA to ensure the safety and effectiveness of drug products on the market, and assists clients in a wide range of compliance and enforcement matters. She also advises clients on user fee issues, federal and state Sunshine Act reporting obligations, state price transparency disclosure rules, and state licensing requirements.

Tina is a thought leader on artificial intelligence and machine learning in the life sciences industry. She has spoken frequently and published several articles on AI/ML in drug discovery and development as well as FDA's regulation of AI/ML-powered medical devices.

Tina is also a member of the firm's cannabis group, where she assists companies in navigating federal and state law issues related to the promotion and sale of cannabis-related products. Tina has helped companies work to bring FDA- approved cannabinoid drug products to market, as well as helped clients to navigate sale of cannabis and hemp-related products.

Tina chairs the Buchanan B.O.L.D. Affinity group, and is conversant in Mandarin.

In 2019 and 2020, Tina was named to the Washington, D.C. Super Lawyers Rising Stars list. Most recently, in 2024, Tina was named the Rising Star Award winner by the Leadership Council on Legal Diversity.

Louis P. Kassa III, MPA, is Chief Executive Officer of the Pennsylvania Biotechnology Center (PABC), Baruch S. Blumberg Institute and Hepatitis B Foundation, and President of the PABC. He joined the organizations as Executive Vice President and Chief Operating Officer in 2014.

Kassa oversees strategic planning, finance, business development and compliance at the PABC, which is home to the Hepatitis B Foundation, and its research arm, the Baruch S. Blumberg Institute. The PABC's primary location, which is in Doylestown, opened for business in 2006. In partnership with Brandywine Realty Trust, Kassa led the launch of B+labs, a state-of-the-art incubator at Cira Centre in University City, Philadelphia, in 2022. He oversaw the opening of a $20 million building in Doylestown, the fourth on the PABC campus, which provided new labs and offices plus an events space, in 2022.

Kassa founded the Hatch Biofund through the PABC, which is projected to be a $50 million venture capital fund serving the region. With the support of a $5 million state grant, Kassa established the Academic Innovation Zone at the PABC in 2023. In October 2024, New York state officials announced that BioGenesis, a new cell and gene therapy center on Long Island, will offer an incubator to be led by Kassa and Blumberg Institute team.

Kassa worked part-time as the Chief Executive Officer for Youth Services Agency, a non-profit social services agency, from 2015 to 2017. He co-founded Family Foundations Partnership in 2017 and currently is Chief Executive Officer. He previously served as State Director and Chief Operating Officer at VisionQuest National, Ltd., a national behavioral health company.

Kassa was named to the Philadelphia Business Journal's 2026 "Power 100" list of the region's top business leaders, a distinction he has earned annually starting in 2023. He was named to the "10 Best COOs of 2020" by Industry Era, a global tech media outlet.

A Bucks County resident, Kassa was awarded an honorary Doctor of Humane Letters from Holy Family University in 2025. He earned an undergraduate degree at Penn State University and a Master of Public Administration from Villanova University.

Kassa is a board member of numerous organizations: Bucks County Workforce Development Board, Central Bucks Chamber of Commerce, Startup Bucks, Yards Sciences, Bucks County Music Project, Family Foundations Partnership and Triumph in Recovery.